HCPCS Code C1889: Implantable/insertable device

Key Takeaways

HCPCS Code C1889 describes an implantable or insertable device, not otherwise classified – the catch-all Level II code for devices without a more specific HCPCS designation.

Use C1889 only when no specific HCPCS C-code describes the device; once a dedicated code exists, coders must switch to that code.

C1889 is valid for hospital outpatient and ASC claims only – it cannot be billed on physician office claims or Part B professional claims.

Pabau’s claims management tools support accurate device code tracking and UB-04 claim preparation across outpatient billing workflows.

Most implantable device billing runs smoothly when a specific HCPCS code exists. The problem comes when a device hits the market before CMS assigns it a dedicated code – or when a device simply falls outside every existing category. That gap is where most claim errors, underpayments, and outright denials happen. Proper claims management workflows depend on understanding exactly when C1889 applies and how to report it correctly.

This guide covers HCPCS Code C1889 in full: its official descriptor, the CMS device-intensive procedure framework, ASC and hospital outpatient billing rules, documentation requirements, and the real-world devices most commonly reported under this code.

HCPCS Code C1889: definition and code description

HCPCS Code C1889 carries the full descriptor: Implantable/insertable device, not otherwise classified. The short descriptor used on claim forms is “Implant/insert device, noc.” Both forms appear on the CMS HCPCS Level II code set, which is maintained by CMS (Centers for Medicare and Medicaid Services).

C1889 sits within the C-codes category of HCPCS Level II. C-codes cover outpatient prospective payment system (OPPS) items including drugs, biologicals, and devices used in hospital outpatient and ambulatory surgery center (ASC) procedures. Unlike A-codes or E-codes, C-codes are not valid for physician office claims.

The “not otherwise classified” (NOC) designation is the key. C1889 is a catch-all – it only applies when no other HCPCS code accurately describes the device being reported. When a more specific C-code does exist, coders must use that code instead.

When to use HCPCS Code C1889 instead of a specific device code

The decision tree for C1889 follows a single rule: exhaust specific codes first. According to AAPC Codify, coders should review the full C-code range before defaulting to the NOC code.

1. Identify the device. Confirm the device is implantable or insertable. Devices that are purely external or topical do not qualify under C1889.
2. Search for a specific HCPCS code. Check the current HCPCS Level II code set for a C-code that precisely describes the device by function, material, or category (e.g., C1769 for guide wires, C1776 for joint implants, C1781 for implantable mesh).
3. Verify the procedure code pairing. Check whether the procedure code being billed triggers a device-intensive designation under CMS. If it does and no specific device code exists, C1889 is appropriate.
4. Report C1889 with charges. Per CMS Transmittal R11305CP, hospitals report C1889 along with all charges for the devices used. CMS uses the charge data to calculate the device offset in the APC payment.
5. Document the specific device. The medical record must identify the exact device by brand name, manufacturer, and model or catalog number. Generic entries such as “implant used” are not sufficient.

One critical point: if a manufacturer later obtains a dedicated HCPCS code for a device that was previously reported under C1889, the billing team must transition to that specific code immediately. Continuing to use C1889 after a designated code is available can trigger claim audits.

C1889 and device-intensive procedures: how CMS payment works

CMS designates certain OPPS ambulatory payment classifications (APCs) as device-intensive procedures. These are procedures where the device cost represents a substantial share of total procedure cost. Understanding how this affects C1889 reimbursement is essential for outpatient billing accuracy.

When a procedure falls into a device-intensive APC, CMS applies a device offset – a portion of the APC payment is set aside to cover the device cost. For device-intensive procedures where the hospital uses a device without a specific HCPCS code, CMS instructs hospitals to report C1889 and submit the device charges. CMS then applies a device offset percentage to calculate the payment contribution for the device.

Palmetto GBA, a Medicare Administrative Contractor (MAC), maintains a Device-Intensive Procedure and Device Code Search tool that lists which procedure codes trigger device-intensive status and which device HCPCS codes (including C1889) may be reported with them. Coders should verify current pairings using this tool before submitting claims.

Pass-through status and C1889

C1889 itself is not a pass-through code. Pass-through payment status applies to specific devices that have received a temporary additional payment outside the APC rate, typically because the device is new and its costs are not yet reflected in the APC. When a specific device has pass-through status, CMS assigns a dedicated C-code for it, not C1889.

If a device previously reported under C1889 later receives pass-through status and a designated code, that dedicated code must replace C1889 immediately. Reporting C1889 for a device that now has a pass-through code means the provider misses the additional payment and may draw audit attention. Tracking these transitions is part of sound automated billing workflows in any outpatient setting.

ASC billing with HCPCS Code C1889

Ambulatory surgery centers operate under the ASC payment system, which is separate from OPPS. The rules for reporting implantable devices in ASCs differ from hospital outpatient departments, and C1889 applies in both settings but with different reimbursement logic.

Under the ASC payment system, many device costs are packaged into the facility fee. ASCs do not always receive separate device payment. For certain procedures, however, CMS allows separate payment for implantable devices. When a procedure qualifies for device carve-out or separate payment in an ASC and the device used does not have a specific HCPCS code, C1889 is the appropriate code to report.

ASC coders should also confirm whether the procedure is on the ASC-covered procedures list. Only procedures CMS has approved for ASC billing generate separate facility payment. Procedures not on the list may still use C1889 for the device, but separate payment is unlikely. Practices managing ASC billing alongside outpatient services benefit from EHR integration for billing teams that keeps device coding consistent across settings.

ASC vs. hospital outpatient: key billing differences for C1889

Streamline your device billing workflows with Pabau

Pabau's claims management tools help outpatient and ASC billing teams track device codes, prepare UB-04 claims, and maintain the documentation records that audits demand.

Book a demo

Common devices reported under HCPCS Code C1889

Several commercially available devices are routinely billed under C1889 because CMS has not assigned them a dedicated HCPCS code. These are verified examples drawn from manufacturer reimbursement guides and MAC guidance.

SpaceOAR hydrogel

SpaceOAR hydrogel (Boston Scientific) is an absorbable synthetic hydrogel spacer placed between the prostate and rectum before prostate radiotherapy. CMS considers SpaceOAR placement a device-intensive procedure, and the SpaceOAR material must be reported with C1889 on the same claim form as the placement procedure code. This is confirmed in Boston Scientific’s 2026 Coding and Payment Quick Reference for SpaceOAR.

Optilume drug-coated balloon

The Optilume device (Laborie Medical Technologies) is a drug-coated balloon catheter used to treat urethral stricture. Because there is currently no unique HCPCS code to describe the Optilume device, Laborie’s reimbursement guidance confirms that the most appropriate code is C1889. Coders should pair it with the applicable procedure code for urethral stricture treatment.

Susvimo ranibizumab implant port

Susvimo (Genentech) is an ocular implant port that delivers ranibizumab continuously for diabetic macular edema and other retinal conditions. For Medicare hospital outpatient claims, Genentech’s Access Solutions billing guide confirms that hospital outpatient departments should report the cost of the implant using C1889, separate from the drug administration code for the ranibizumab itself.

These examples illustrate how device manufacturers publish reimbursement guides specifically because C1889 is not self-explanatory. Billing teams should check current manufacturer reimbursement guides annually, since dedicated codes can be assigned at any time. Maintaining these resources alongside HIPAA-compliant documentation practices is part of a defensible billing program.

Documentation requirements for C1889 claims

C1889 claims draw scrutiny precisely because the code is broad. A claim that simply lists C1889 with a charge amount gives an auditor nothing to verify. Complete documentation protects the claim and supports the facility if a MAC or OIG review occurs.

Required elements in the medical record

• Device identification. Brand name, manufacturer name, model or catalog number, and serial or lot number where applicable.
• Clinical indication. The procedure note must clearly explain why the device was used and its role in the procedure.
• Procedure code pairing. The device report must tie to a specific procedure code on the same claim. CMS does not accept C1889 as a standalone line item without an associated procedure.
• Charges. The actual cost of the device must be submitted with the claim. CMS uses charge data to calculate the device cost offset within the APC payment methodology.
• Confirmation of no specific code. While not always a formal requirement, some MACs expect evidence that no more specific HCPCS code was available for the device at the time of billing. Documenting the code search in the billing record supports this.

Using digital intake and device forms that capture device lot numbers, catalog references, and clinical notes at the point of care reduces the documentation burden on billing staff considerably. Facilities that capture device details during the procedure rather than reconstructing them from purchase orders tend to see fewer documentation-related denials. A structured compliance documentation checklist for device-intensive procedures is a practical starting point for outpatient facilities.

Revenue cycle impact: claim denials and prevention

C1889 claims fail for a predictable set of reasons. Understanding the denial pattern helps billing managers build edits and review steps before submission.

Common denial reasons

• Specific code available. A dedicated HCPCS code exists for the device and C1889 was used instead. This is the most avoidable denial category.
• Missing procedure code pairing. C1889 was submitted without the associated procedure code on the same claim, leaving the device line with no clinical context.
• Bundling. The device cost is already packaged into the APC payment for the procedure and cannot be billed separately. Coders must verify device-intensive status and offset applicability before billing.
• Invalid setting. C1889 submitted on a professional claim or physician office UB-04 line. The code is restricted to facility claims from HOPDs and ASCs.
• Insufficient documentation. The claim was reviewed and the supporting record lacked the device identification details CMS or the MAC required.

Prevention starts at the workflow level. Billing teams that receive device information directly from the procedure note or operative report, rather than from informal communication with clinical staff, are less likely to submit incomplete claims. Connecting clinical documentation to the practice management software that feeds the billing queue creates a more reliable data path for device coding. Facilities managing high volumes of device-intensive procedures also benefit from dedicated claim edits that flag C1889 lines for secondary review before submission.

The CMS Physician Fee Schedule lookup and the PGM Billing HCPCS lookup tool are practical resources for verifying code status and payment indicators before claim submission. Both are freely available and draw from current CMS data.

C1889 and related HCPCS device codes

Coders working with C1889 regularly encounter adjacent codes that cover specific device categories. Knowing these prevents misuse of the NOC code and supports accurate billing across implant types.

• C1769: Guide wire – used for insertable guide wire devices in vascular and other procedures.
• C1776: Joint device (implantable) – covers implantable joint replacement components.
• C1781: Mesh (implantable) – covers surgical mesh used in hernia repair and other procedures.
• C1883: Adapter/extension, pacing lead or neurostimulator lead – specific to pacing lead accessories.
• C1894: Introducer/sheath, other than guiding, intracardiac electrophysiological – covers sheaths not classified elsewhere.

Each of these codes represents a device category that once had no specific code and was billed under C1889 or a predecessor NOC code. When CMS assigns a specific code, it signals that the device category has sufficient volume and cost data to warrant its own classification. Tracking these transitions is part of annual code update review. Resources such as AAPC Codify publish updated HCPCS code sets each January with change summaries that flag new, revised, and deleted codes.

Billing teams managing both implantable devices and associated procedure coding can also benefit from reviewing CPT code billing guidance alongside HCPCS references, since many device-intensive procedures require both a CPT procedure code and a HCPCS device code on the same claim. For fertility and reproductive procedure lines where device billing intersects with procedure coding, device-related procedure coding guidance provides additional context on pairing conventions.

Conclusion

C1889 fills a necessary gap in HCPCS Level II, but “not otherwise classified” should not mean “not well documented.” Every C1889 claim needs a specific device on record, a paired procedure code, submitted charges, and confirmation that no specific HCPCS code was available. Facilities that treat C1889 as a default rather than a last resort will see denial rates climb and audit risk rise.

Pabau’s claims management software helps outpatient and ASC billing teams build the documentation trails and claim preparation workflows that device-intensive billing demands. To see how Pabau supports accurate device code reporting and plastic surgery practice billing tools in procedure-heavy settings, book a demo.

Continue your research

Need a structured approach to outpatient compliance documentation? Medical spa compliance checklist covers the documentation standards that protect facilities during audits.

Looking to reduce administrative burden on billing staff? Digital intake and device forms capture the device details your claims need at the point of care.

Managing billing across multiple practice systems? EHR integration for billing teams outlines how connected systems reduce device coding errors.

Frequently Asked Questions